ArticleInternational journal of cancer2025
Understanding delays in breast cancer diagnosis in Africa: Key insights and contributing factors.
Article in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Supportive care needs among patients with breast and cervical cancer at a tertiary cancer treatment center in ethiopia: a cross-sectional study.Scientific reports · 2026Article
- Understanding delays in breast cancer diagnosis in Africa: Key insights and contributing factors.International journal of cancer · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Africa has the highest age-standardized breast cancer (BC) mortality rates, largely due to diagnostic delays. Therefore, this scoping review aims to identify individual-level factors that contribute to diagnostic delay of BC in African women. We conducted a global scoping review on cancer diagnostic delays in women, following PRISMA-ScR guidelines. In this scoping review, diagnostic delay is defined as the time from first symptom recognition to pathological diagnosis. Qualitative and quantitative studies involving cancer patients or healthcare professionals published between 2018 and November 28, 2023, were included. We searched PubMed/MEDLINE and Scopus, excluding non-English studies and those focused solely on screening. Two reviewers independently screened titles, full texts, and extracted data. Disagreements were resolved by discussion. Consultations followed Arksey and O'Malley's framework, with input from a general practitioner, psychologist, and epidemiologist. Factors were classified using Bronfenbrenner's ecological model to analyze BC diagnostic delays in Africa. Of 9699 studies, 128 were relevant; 30 focused on African BC patients. Delays were linked to microsystem factors: lack of awareness, fear, young age, low education, finances, mesosystem factors: family duties, limited access, delayed care, symptom disclosure, exosystem factors: traditional healers, mistrust, referral inefficiencies, and macrosystem factors: religious beliefs, education gaps, cultural norms. Diagnostic delays in women with BC in Africa are mainly due to low awareness, cultural beliefs, and reliance on traditional healers. Expanding current interventions and integrating them into healthcare systems, along with engaging religious leaders, is important. Future research should focus on culturally tailored strategies to improve early detection and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.